Histopathological biomarkers for predicting the tumour accumulation of nanomedicines
Jan‐Niklas May(RWTH Aachen University), Twan Lammers(RWTH Aachen University)
Cited by 43
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535
Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation
|Nano Today|2015|499
Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications
|Chemical Society Reviews|2022|390